Investor Relations

Here you will find details on our share as well as detailed information on key figures, annual and quarterly results, IR events and much more.

2018: IFRS results

HAEMATO AG achieved consolidated sales of EUR 274.1m, an operating result (EBIT) of EUR 8.5m and net profit of EUR 6.3m in the 2018 financial year, taking into account IFRS 15 “Revenues”,
which must be applied from the 2018 financial year onwards.
A capital increase of EUR 5.2m to replace profit participation certificates improved the equity ratio from 57.2% (2017) to 65.0% in 2018 and contributed, among other things, to a significant reduction in financial liabilities by a total of EUR 10.9m.

Sales

EBIT

Net Income

%

Equity Ratio

Performance

Get information about the HAEMATO AG share and get an overview of the current price development.

Rating & Research

Here you will find well-founded stock analyses of renowned research houses and banks on the HAEMATO AG share.

BUY: 6.15 €

GBC AG, 27 May 2019

ADD: 5.80 €

Berlin Equity Research, 17 May 2019

BUY: 7.60 €

Berlin Equity Research, 13 September 2018

HAEMATO AG

HAEMATO AG
Lilienthalstraße 5c
12529 Schönefeld
Germany

Phone: +49-30 897 30 86 70
Telefax: +49-30 897 30 86 79
E-Mail: info@haemato.ag